FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3089271785> ?p ?o ?g. }

• W3089271785 endingPage "e22981" @default.
• W3089271785 startingPage "e22981" @default.
• W3089271785 abstract "Prostatitis is a common urogenital system disease in men which affects 5% to 9% of adult men worldwide and accounts for approximately 8% of visits to urologists. In the past years, its pathogenesis is complicated and the classification of it is not clear, so the effect of treatment measures is not significant. Recently, the treatment of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) includes nonsteroidal anti-inflammatory drugs, phytotherapy, hormonal therapy, alpha-blockers, anti-anxiolytic, and acupuncture, which provide more choice for the urologist. But there still are some limitations. scholars. Many studies suggest radial extracorporeal shock wave therapy may be the better option in the treatment of CP/CPPS. However, the efficacy and safety of it still lack solid evidence.The electronic databases of MEDLINE, PubMed, Web of Science, EMBASE, Cochrane Library, Clinicaltrials.org, China National Knowledge Infrastructure Database, Wan fang Database, China Biology Medicine Database, VIP Science Technology Periodical Database, Chinese Clinical Trial Registry will be retrieved. All the randomized controlled trials of radial extracorporeal shock wave therapy (rESWT) for patients with CP/CPPS will be included. We will evaluate the outcomes including National Institutes of Health Chronic Prostatitis Symptom Index, visual analog scale, international prostate symptom score, international index of erectile function-5, and conduct this study strictly according to the Cochrane Handbook for Systematic Reviews of Interventions.The current study is a protocol for systematic review and meta-analysis without results, and data analysis will be carried out after the protocol. We will share our findings on October 31st of 2021.rESWT as a noninvasive treatment with no pain, which will be accepted more easily. Although some studies have suggested that rESWT can relieve the symptoms of patients, the efficacy and safety of it still lack solid evidence. To address this limitation scientifically and systematically, this study will inspect the efficacy and safety of the rESWT treatment in patients with CP/CPPS by integrating various studies.Formal ethical approval is not required in this protocol. We will collect and analyze data based on published studies, and since there are no patients involved in this study, individual privacy will not be under concerns. The results of this review will be disseminated to peer-reviewed journals or submit to related conferences.INPLASY202090076." @default.
• W3089271785 created "2020-10-01" @default.
• W3089271785 creator A5020450164 @default.
• W3089271785 creator A5022166907 @default.
• W3089271785 creator A5028002427 @default.
• W3089271785 creator A5051615689 @default.
• W3089271785 creator A5054325653 @default.
• W3089271785 creator A5056957683 @default.
• W3089271785 creator A5057747738 @default.
• W3089271785 creator A5082260987 @default.
• W3089271785 date "2020-10-30" @default.
• W3089271785 modified "2023-09-26" @default.
• W3089271785 title "Efficacy of radial extracorporeal shock wave therapy for chronic prostatitis/chronic pelvic pain syndrome" @default.
• W3089271785 cites W1572187112 @default.
• W3089271785 cites W1607509725 @default.
• W3089271785 cites W1968726185 @default.
• W3089271785 cites W1973214716 @default.
• W3089271785 cites W1997393900 @default.
• W3089271785 cites W1997517088 @default.
• W3089271785 cites W2037558979 @default.
• W3089271785 cites W2077166822 @default.
• W3089271785 cites W2078397510 @default.
• W3089271785 cites W2113266440 @default.
• W3089271785 cites W2120578794 @default.
• W3089271785 cites W2142820536 @default.
• W3089271785 cites W2156098321 @default.
• W3089271785 cites W2161374186 @default.
• W3089271785 cites W2165010366 @default.
• W3089271785 cites W246286872 @default.
• W3089271785 cites W2529676578 @default.
• W3089271785 cites W2749546593 @default.
• W3089271785 cites W2767325459 @default.
• W3089271785 cites W2800833953 @default.
• W3089271785 cites W2891976012 @default.
• W3089271785 cites W2902601029 @default.
• W3089271785 cites W2942950092 @default.
• W3089271785 cites W2983456953 @default.
• W3089271785 cites W4294215472 @default.
• W3089271785 doi "https://doi.org/10.1097/md.0000000000022981" @default.
• W3089271785 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7598797" @default.
• W3089271785 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33126371" @default.
• W3089271785 hasPublicationYear "2020" @default.
• W3089271785 type Work @default.
• W3089271785 sameAs 3089271785 @default.
• W3089271785 citedByCount "2" @default.
• W3089271785 countsByYear W30892717852022 @default.
• W3089271785 crossrefType "journal-article" @default.
• W3089271785 hasAuthorship W3089271785A5020450164 @default.
• W3089271785 hasAuthorship W3089271785A5022166907 @default.
• W3089271785 hasAuthorship W3089271785A5028002427 @default.
• W3089271785 hasAuthorship W3089271785A5051615689 @default.
• W3089271785 hasAuthorship W3089271785A5054325653 @default.
• W3089271785 hasAuthorship W3089271785A5056957683 @default.
• W3089271785 hasAuthorship W3089271785A5057747738 @default.
• W3089271785 hasAuthorship W3089271785A5082260987 @default.
• W3089271785 hasBestOaLocation W30892717851 @default.
• W3089271785 hasConcept C121608353 @default.
• W3089271785 hasConcept C126322002 @default.
• W3089271785 hasConcept C141071460 @default.
• W3089271785 hasConcept C168563851 @default.
• W3089271785 hasConcept C17744445 @default.
• W3089271785 hasConcept C177713679 @default.
• W3089271785 hasConcept C1862650 @default.
• W3089271785 hasConcept C199539241 @default.
• W3089271785 hasConcept C2776235491 @default.
• W3089271785 hasConcept C2776362571 @default.
• W3089271785 hasConcept C2776478404 @default.
• W3089271785 hasConcept C2779473830 @default.
• W3089271785 hasConcept C2780136519 @default.
• W3089271785 hasConcept C2780524745 @default.
• W3089271785 hasConcept C71924100 @default.
• W3089271785 hasConceptScore W3089271785C121608353 @default.
• W3089271785 hasConceptScore W3089271785C126322002 @default.
• W3089271785 hasConceptScore W3089271785C141071460 @default.
• W3089271785 hasConceptScore W3089271785C168563851 @default.
• W3089271785 hasConceptScore W3089271785C17744445 @default.
• W3089271785 hasConceptScore W3089271785C177713679 @default.
• W3089271785 hasConceptScore W3089271785C1862650 @default.
• W3089271785 hasConceptScore W3089271785C199539241 @default.
• W3089271785 hasConceptScore W3089271785C2776235491 @default.
• W3089271785 hasConceptScore W3089271785C2776362571 @default.
• W3089271785 hasConceptScore W3089271785C2776478404 @default.
• W3089271785 hasConceptScore W3089271785C2779473830 @default.
• W3089271785 hasConceptScore W3089271785C2780136519 @default.
• W3089271785 hasConceptScore W3089271785C2780524745 @default.
• W3089271785 hasConceptScore W3089271785C71924100 @default.
• W3089271785 hasIssue "44" @default.
• W3089271785 hasLocation W30892717851 @default.
• W3089271785 hasLocation W30892717852 @default.
• W3089271785 hasLocation W30892717853 @default.
• W3089271785 hasLocation W30892717854 @default.
• W3089271785 hasOpenAccess W3089271785 @default.
• W3089271785 hasPrimaryLocation W30892717851 @default.
• W3089271785 hasRelatedWork W1981765034 @default.
• W3089271785 hasRelatedWork W2038464024 @default.
• W3089271785 hasRelatedWork W2329658345 @default.
• W3089271785 hasRelatedWork W2941297716 @default.
• W3089271785 hasRelatedWork W2941954413 @default.

• next